Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21511,777,0.99 [0.87-1.12],0.8492428248804145
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21510,125,1.00 [0.74-1.36],0.9769998789343168
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22857,127,0.93 [0.67-1.29],0.6784534593350355
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17047,431,1.09 [0.93-1.28],0.2911709023231711
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22806,76,0.97 [0.65-1.46],0.8990416634676489
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22193,70,0.78 [0.47-1.29],0.3314062460843626
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23672,75,1.00 [0.67-1.48],0.988275548721531
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23691,49,1.12 [0.72-1.73],0.6172569962578657
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21715,40,0.76 [0.38-1.50],0.4241221049002641
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23250,95,0.81 [0.53-1.24],0.3327204633505907
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other septicaemia,23216,61,0.70 [0.39-1.25],0.2286360335482268
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23734,58,0.64 [0.35-1.19],0.1596098054615876
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other viral diseases,23694,92,0.83 [0.55-1.26],0.3871725568505813
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23686,84,0.82 [0.53-1.28],0.3861358908485399
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Mycoses,23532,44,0.91 [0.51-1.62],0.7487753927516239
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22978,333,1.09 [0.92-1.29],0.312648307084644
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22766,121,1.19 [0.93-1.53],0.1687923066937403
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22861,216,1.12 [0.91-1.37],0.2949926402944988
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",20584,25,1.11 [0.60-2.08],0.7338980285923654
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20603,44,0.77 [0.40-1.46],0.4185962875913054
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20668,109,1.09 [0.81-1.47],0.5684439722112713
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20673,114,1.07 [0.80-1.45],0.6368743976412181
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",11580,252,1.11 [0.92-1.34],0.2897795566483137
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9253,22,1.41 [0.88-2.25],0.1568881594389592
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20601,42,0.73 [0.37-1.45],0.3680947607106001
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21930,703,1.18 [1.05-1.32],0.0037823026514147
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22856,173,0.92 [0.69-1.22],0.5617538588412254
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23384,71,1.10 [0.76-1.59],0.6247846898395424
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23800,66,0.88 [0.55-1.42],0.6107261386914729
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Rectum,23601,39,0.93 [0.52-1.67],0.8202291764751444
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23798,34,1.09 [0.65-1.84],0.740813881286069
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Stomach,23834,27,1.14 [0.65-1.99],0.6479763821899717
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm,23571,253,1.04 [0.85-1.28],0.6922516672251338
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23776,105,0.98 [0.70-1.38],0.9262470689349518
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23781,77,1.10 [0.77-1.57],0.5848717860228916
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23752,42,1.27 [0.85-1.89],0.2372312461338452
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Haemangioma, any site",23754,42,1.27 [0.85-1.89],0.2372679664033924
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Melanocytic naevi,23654,208,0.92 [0.72-1.19],0.5345781892268457
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23801,92,0.75 [0.48-1.17],0.2035503377991478
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Other benign neoplasms of skin,23721,158,1.22 [0.98-1.51],0.076507966817225
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of breast,13153,81,0.86 [0.57-1.31],0.4826406734871491
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Leiomyoma of uterus,12864,592,1.11 [0.98-1.26],0.1006079653148168
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22988,166,1.32 [1.09-1.60],0.0044162616695964
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22877,299,1.14 [0.95-1.35],0.1530060627070264
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22877,299,1.14 [0.95-1.35],0.1530060627070264
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21837,307,0.98 [0.80-1.19],0.8212838284564716
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23400,74,1.16 [0.83-1.62],0.3952340351030956
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23619,83,0.92 [0.62-1.38],0.69739127294381
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,20887,606,0.86 [0.73-1.01],0.0718920709420233
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22750,367,1.19 [1.03-1.38],0.0204503829431887
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22265,87,1.06 [0.75-1.49],0.7564122243617595
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Peripheral artery disease,23169,52,0.94 [0.57-1.56],0.819761309480789
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22254,76,1.06 [0.73-1.52],0.7609671898789336
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22459,281,1.01 [0.83-1.24],0.9005457481816445
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22452,274,1.03 [0.84-1.26],0.8070184724122227
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22163,152,1.02 [0.76-1.37],0.8864400768593244
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22166,149,1.05 [0.78-1.41],0.7544447332588139
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20752,471,0.82 [0.68-0.99],0.0387973890243287
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20346,65,0.99 [0.64-1.53],0.9503766830596454
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,20715,434,0.81 [0.67-0.99],0.0403573901110801
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20321,40,0.87 [0.47-1.60],0.6494648666460543
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20341,60,0.96 [0.61-1.53],0.8741756712935578
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Any mental disorder,20654,661,0.98 [0.85-1.13],0.789374259448919
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20261,268,0.89 [0.70-1.14],0.3471379504057885
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23470,202,0.99 [0.78-1.27],0.9657792208729844
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23521,147,0.91 [0.66-1.24],0.5399358507872358
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22119,71,1.02 [0.68-1.51],0.9350153677022806
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23741,71,1.02 [0.69-1.51],0.91411478143697
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",20064,71,1.02 [0.68-1.52],0.9305244764141374
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Alcohol dependence,22135,87,0.94 [0.63-1.40],0.750664319177017
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Smoking dependency,22089,64,0.99 [0.62-1.57],0.963556925184858
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20060,67,0.88 [0.55-1.41],0.5891508532277806
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20316,323,1.04 [0.87-1.26],0.6416344951827467
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Depression,22338,282,1.03 [0.84-1.26],0.7703258483343375
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Depression or dysthymia,20195,246,1.01 [0.81-1.25],0.9443239486343652
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20119,126,1.04 [0.78-1.39],0.7905481835356691
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Other anxiety disorders,22553,57,1.21 [0.85-1.73],0.2925938808909926
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Neurological diseases,21222,1274,1.04 [0.95-1.15],0.3881514377850328
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19763,157,1.15 [0.91-1.45],0.2555418727398766
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23651,128,1.17 [0.91-1.50],0.2236410601067113
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22698,423,0.94 [0.79-1.12],0.479318330993806
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Epilepsy,22420,145,1.05 [0.80-1.37],0.7398206500084212
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Migraine,22359,84,0.67 [0.41-1.11],0.1208842883536794
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23520,75,0.71 [0.43-1.19],0.1966931159237466
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Transient ischemic attack,23406,36,0.65 [0.30-1.41],0.2771758745871963
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other sleep disorders,22424,149,0.97 [0.73-1.29],0.8340847206629162
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Sleep apnoea,23309,115,0.98 [0.71-1.34],0.8792961645412928
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22853,540,1.03 [0.89-1.20],0.6563279865907433
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22434,121,1.07 [0.81-1.43],0.634258239657967
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22604,291,1.09 [0.91-1.31],0.3556766175867444
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23649,75,1.09 [0.76-1.57],0.6221931468076594
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Hemiplegia,23623,49,1.22 [0.82-1.81],0.3289989887609342
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other neurological diseases,23460,106,1.08 [0.80-1.47],0.598062146251134
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23430,266,0.95 [0.77-1.19],0.6798968853291323
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23305,141,0.73 [0.51-1.06],0.0992584494828142
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23241,77,1.08 [0.76-1.54],0.6738353189686745
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23247,83,0.77 [0.48-1.22],0.261625396586951
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23204,40,1.31 [0.90-1.92],0.156678372790752
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22350,51,1.26 [0.87-1.84],0.2262465723244603
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22453,154,0.97 [0.72-1.30],0.8302166104620373
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23305,108,0.97 [0.69-1.37],0.8567985203912298
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23617,18,1.10 [0.52-2.31],0.803769639429573
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1505,18,1.09 [0.50-2.40],0.8280618262521174
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22130,18,1.10 [0.52-2.31],0.8018300947115075
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23507,43,1.03 [0.62-1.72],0.8977308140190623
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23487,23,0.87 [0.38-1.98],0.7409787595670281
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23425,81,1.13 [0.81-1.56],0.4820711807247686
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23475,89,1.12 [0.82-1.54],0.4802161411182987
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23718,107,0.76 [0.50-1.15],0.1946309142691042
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,23385,87,1.02 [0.71-1.45],0.9319553096849696
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18600,1697,0.98 [0.90-1.08],0.7421713592637641
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23564,38,1.08 [0.65-1.79],0.7656686644678021
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Hypertension, essential",19515,1136,0.96 [0.85-1.07],0.4332254084804153
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Hypertension,19529,1150,0.96 [0.85-1.07],0.4343548826779886
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18409,30,0.69 [0.30-1.61],0.3935225173173424
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22544,496,1.03 [0.88-1.20],0.7277966997854265
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Angina pectoris,22352,304,1.08 [0.90-1.30],0.4317086590745584
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23222,121,0.84 [0.59-1.22],0.3645843895038851
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23325,224,0.94 [0.73-1.20],0.6058576054614627
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23742,51,0.85 [0.49-1.48],0.5668369321849298
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22185,137,0.97 [0.72-1.32],0.8578605084019516
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22410,372,1.05 [0.88-1.24],0.6073928751162775
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Pulmonary embolism,23395,75,1.26 [0.94-1.69],0.1208515320816959
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Venous thromboembolism,23394,155,1.24 [1.00-1.52],0.0472559221782068
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Secondary right heart disease,23378,58,1.40 [1.05-1.87],0.0211708055372679
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23378,58,1.40 [1.05-1.87],0.0211708055372679
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18435,56,1.44 [1.08-1.92],0.0138399090408157
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Cardiomyopathy,21569,38,1.25 [0.83-1.88],0.2779327666749477
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Conduction disorders,21596,65,1.15 [0.81-1.65],0.4336299943890006
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16214,83,1.13 [0.82-1.57],0.4508890268735697
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16302,171,0.98 [0.75-1.28],0.8837614065117673
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other arrhythmias,21566,35,1.01 [0.56-1.80],0.9848468040785432
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21582,51,1.37 [1.00-1.88],0.0506770759699783
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Heart failure, strict",23400,109,0.92 [0.65-1.32],0.65817572999743
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23363,98,1.06 [0.77-1.46],0.7254331786798902
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23393,74,1.11 [0.78-1.58],0.5625242183368766
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23435,65,1.12 [0.77-1.62],0.5653970035682091
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23182,44,0.54 [0.25-1.18],0.1235038580270488
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23214,76,1.19 [0.86-1.64],0.3015726341497068
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22789,100,1.22 [0.94-1.59],0.1264413299102896
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,DVT of lower extremities,22772,83,1.15 [0.84-1.58],0.3907360836653442
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23696,80,1.16 [0.85-1.59],0.3606982544557835
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Varicose veins,23067,378,1.19 [1.03-1.38],0.0163813902019455
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Hypotension,23214,45,1.05 [0.64-1.70],0.8508104130144253
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20156,1686,1.07 [0.99-1.16],0.0965417754003288
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23636,115,1.24 [0.97-1.59],0.081131620070049
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Influenza and pneumonia,22811,159,1.02 [0.78-1.34],0.8696095174752616
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22786,134,1.06 [0.80-1.40],0.6832957465645568
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23286,193,1.25 [1.03-1.51],0.0215155881269224
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23285,192,1.25 [1.03-1.51],0.0226351352453411
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23061,570,0.91 [0.77-1.06],0.2144959925938014
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Chronic sinusitis,22578,87,0.69 [0.43-1.13],0.1401219535374768
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Nasal polyp,22587,96,1.01 [0.72-1.42],0.9453706011506976
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22853,362,0.79 [0.64-0.98],0.0341091443749415
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Deviated nasal septum,22679,188,0.91 [0.70-1.19],0.4862681545912214
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13682,42,0.71 [0.34-1.46],0.3474175919157698
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21802,766,1.15 [1.03-1.28],0.0111302358180548
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Early onset COPD,23217,85,0.61 [0.36-1.06],0.0819459459682543
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23217,85,0.61 [0.36-1.06],0.0819459459682543
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",23217,85,0.61 [0.36-1.06],0.0819459459682543
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22314,694,1.15 [1.03-1.29],0.0167124274458925
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Asthma,18191,694,1.14 [1.02-1.28],0.024521030071634
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18063,694,1.14 [1.02-1.28],0.0268025925112411
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18176,679,1.15 [1.02-1.29],0.0204930817429793
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23669,54,0.86 [0.50-1.48],0.5913679276209438
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Interstitial lung disease,22659,41,0.79 [0.40-1.54],0.4836875597787204
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23725,41,0.78 [0.40-1.52],0.4654698927860855
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22654,36,0.87 [0.45-1.69],0.6800864921815639
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pleural effusion,22659,65,0.54 [0.29-1.02],0.0571224937573777
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other diseases of pleura,22754,160,0.93 [0.69-1.24],0.618393907517504
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23103,76,1.21 [0.89-1.66],0.2269869482765971
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16929,4442,1.07 [1.01-1.14],0.0216018808251745
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23316,428,1.17 [1.02-1.35],0.0240438440418559
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23772,117,1.16 [0.90-1.50],0.2612852376846548
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Impacted teeth,23777,108,1.19 [0.92-1.55],0.1940819747870159
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Dental caries,22994,106,1.05 [0.76-1.44],0.787129338728367
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22985,97,1.37 [1.08-1.74],0.0098403503395357
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23761,132,1.14 [0.89-1.46],0.3014909132793633
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22966,78,1.28 [0.96-1.70],0.0977741445788052
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22754,56,0.90 [0.54-1.50],0.6834528668811009
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23728,41,1.00 [0.58-1.71],0.9959580475928632
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19172,177,1.05 [0.82-1.35],0.6835275580074613
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20513,1518,1.03 [0.94-1.13],0.5334908945593487
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Oesophagitis,19226,231,1.06 [0.86-1.32],0.5688718935017119
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19479,484,1.06 [0.91-1.24],0.4248841269875616
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19054,59,1.11 [0.74-1.66],0.6230939864089413
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19117,122,0.99 [0.72-1.36],0.9341986539057712
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Oesophageal obstruction,19022,27,0.68 [0.28-1.64],0.3939271677593219
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastric ulcer,19085,90,1.20 [0.88-1.63],0.2458486450764827
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Duodenal ulcer,19084,89,1.04 [0.72-1.48],0.8451709063767054
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23743,63,1.17 [0.82-1.66],0.397810868198056
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Chronic gastritis,19091,96,1.17 [0.87-1.59],0.2953167252357545
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19550,555,1.03 [0.89-1.19],0.6969890680424582
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of appendix,23677,138,0.83 [0.60-1.17],0.293685169616234
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Functional dyspepsia,19331,336,0.98 [0.81-1.20],0.8765255174943986
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19096,101,1.02 [0.73-1.43],0.9001997244788459
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23664,171,1.05 [0.82-1.34],0.7138826392982699
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute appendicitis,23647,108,0.90 [0.63-1.29],0.5614516819136299
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Hernia,21483,1010,1.06 [0.95-1.17],0.2830871369524983
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Inguinal hernia,20807,334,0.99 [0.82-1.20],0.9295033468119248
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Umbilical hernia,20572,99,1.28 [1.00-1.64],0.0526765189780323
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Ventral hernia,20550,77,1.17 [0.84-1.63],0.3586506618950121
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20998,525,1.02 [0.88-1.19],0.785801622410708
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23078,648,0.91 [0.78-1.05],0.1932646683079587
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of intestines,19614,1438,1.05 [0.96-1.15],0.2575827255711496
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23545,64,1.13 [0.78-1.63],0.5156003512170684
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23763,91,1.00 [0.70-1.43],0.987938707424218
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Crohn disease,22521,91,1.00 [0.70-1.43],0.991252866526324
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Crohn's disease NAS,22501,71,1.09 [0.76-1.57],0.6413601296554219
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23711,113,0.85 [0.59-1.23],0.3898918937076363
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Ulcerative colitis,22543,113,0.85 [0.59-1.23],0.389594647177002
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22526,96,0.86 [0.58-1.29],0.4713643292855323
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22950,520,0.87 [0.74-1.04],0.124937468610177
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22946,516,0.88 [0.74-1.04],0.1382764706673134
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18236,60,1.04 [0.68-1.59],0.866795710777332
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Intestinal stricture,23538,60,1.03 [0.68-1.57],0.8859490706992799
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18220,44,1.16 [0.74-1.81],0.5162303968218772
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18442,266,1.06 [0.87-1.30],0.5585565031595923
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18322,146,1.03 [0.78-1.36],0.8145783095603154
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18388,212,1.11 [0.90-1.37],0.3342930896369022
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Constipation,22840,188,1.13 [0.91-1.40],0.285034982437747
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of peritoneum,23472,76,0.89 [0.58-1.38],0.6070018869277971
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18335,159,0.98 [0.74-1.30],0.8994539679910907
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18259,83,1.00 [0.69-1.46],0.990696486287068
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18857,681,1.05 [0.93-1.20],0.433043963238355
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of intestine,18329,153,1.08 [0.83-1.39],0.5819770948518614
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23462,66,0.86 [0.53-1.39],0.5381229275827577
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of liver,23209,108,1.10 [0.82-1.48],0.5372653234968449
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of liver,23163,62,1.03 [0.68-1.56],0.8851368368086381
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22748,449,1.02 [0.87-1.20],0.7776290095581058
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Cholelithiasis,22656,357,1.04 [0.88-1.24],0.6477707390690719
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Cholecystitis,22361,62,0.81 [0.48-1.36],0.4295260623620295
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22334,35,1.10 [0.66-1.84],0.7008481487420617
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute pancreatitis,22349,50,0.77 [0.42-1.41],0.3948454836686481
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23677,50,0.77 [0.42-1.42],0.4009175867568402
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of the digestive system,22753,253,1.16 [0.97-1.40],0.0976285574535782
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Intestinal malabsorption,22562,62,1.55 [1.22-1.96],0.0002850763601328
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Coeliac disease,22550,50,1.58 [1.23-2.03],0.0003603409827617
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22538,38,0.89 [0.48-1.65],0.717963225621909
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22658,158,0.98 [0.75-1.30],0.9068370446755588
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,GI-bleeding,22653,153,0.98 [0.74-1.30],0.9013584006063076
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21627,1290,0.94 [0.85-1.04],0.2275151979325502
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23502,88,0.91 [0.62-1.36],0.6536021526864493
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23472,409,0.94 [0.78-1.12],0.4891594293482505
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22890,448,0.93 [0.78-1.11],0.4156051690859385
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23154,359,0.86 [0.70-1.06],0.1475109621406474
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22893,98,0.65 [0.41-1.05],0.0793512990291935
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22996,201,0.94 [0.73-1.21],0.6106978040867657
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23613,75,1.10 [0.78-1.57],0.5781943697343073
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23600,62,0.92 [0.58-1.47],0.7385066322692074
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23583,45,1.04 [0.64-1.70],0.862556841828743
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23697,28,1.15 [0.66-1.99],0.6185707369548901
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23694,25,1.16 [0.65-2.06],0.6146448307128438
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23122,59,0.93 [0.59-1.48],0.7750920259214771
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23373,310,0.98 [0.80-1.19],0.8216439675308642
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22496,54,0.97 [0.60-1.57],0.9076074175291904
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22528,86,0.98 [0.68-1.42],0.9136358682200776
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22515,73,0.99 [0.66-1.48],0.9604128537919802
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22619,177,0.84 [0.63-1.14],0.2670540619609665
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22597,155,0.87 [0.64-1.18],0.3720346449275744
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18441,3031,1.08 [1.01-1.16],0.0184331025868141
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,19801,1622,0.99 [0.91-1.08],0.8286846380304784
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21722,943,1.15 [1.04-1.27],0.0067205409354311
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18288,109,0.97 [0.69-1.36],0.8416448813517707
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18487,308,1.03 [0.85-1.24],0.7993837821686581
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23541,104,0.94 [0.66-1.34],0.7257583101780527
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23553,92,0.97 [0.67-1.40],0.8770011210682367
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18760,581,0.88 [0.75-1.04],0.1383458429298707
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",20967,581,0.88 [0.75-1.04],0.1274629606302097
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18220,41,1.04 [0.62-1.72],0.8930387226903261
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23513,40,1.05 [0.64-1.71],0.8600783148484885
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18312,133,1.05 [0.79-1.39],0.7589570926969764
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18202,23,0.90 [0.42-1.96],0.7938547881428107
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18290,111,0.82 [0.55-1.20],0.3039392550556082
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23729,57,0.65 [0.35-1.21],0.174321837665149
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18466,287,0.76 [0.59-0.98],0.0357666825456968
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18376,197,0.99 [0.77-1.27],0.9528072981328536
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19243,1064,0.99 [0.89-1.10],0.8270930844104877
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18213,34,1.06 [0.62-1.83],0.8223883491549426
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18327,148,1.24 [0.99-1.54],0.060866154096939
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18202,23,1.05 [0.53-2.07],0.8854951360582561
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18202,23,1.19 [0.67-2.12],0.5587553122609674
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18620,441,0.81 [0.66-0.99],0.0353115145694799
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18546,367,0.73 [0.58-0.92],0.0080442037575141
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18805,245,1.01 [0.81-1.26],0.9332287260081176
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23482,143,1.37 [1.12-1.66],0.0018971744177841
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23376,37,1.39 [0.96-2.02],0.0837927707972
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21279,42,1.09 [0.68-1.74],0.7286768482418617
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21434,197,0.98 [0.76-1.26],0.8679583540165325
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22022,785,1.09 [0.98-1.22],0.1248217509666551
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21358,121,1.02 [0.76-1.38],0.8752636803773957
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21286,49,0.89 [0.52-1.54],0.6893176743138711
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21896,659,1.12 [1.00-1.26],0.0577555870291402
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21288,51,1.23 [0.86-1.76],0.25906524255616
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21457,220,1.08 [0.87-1.34],0.4795047465251398
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21335,98,1.14 [0.85-1.53],0.3774243460807053
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21297,60,0.73 [0.41-1.28],0.2694934424702918
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21357,120,1.31 [1.04-1.64],0.0209899291567787
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21295,58,1.41 [1.06-1.88],0.0171702409798173
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21521,284,0.97 [0.79-1.20],0.782685434365228
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21018,239,0.98 [0.78-1.24],0.8923024454571271
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20823,44,1.06 [0.65-1.73],0.809624494717521
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20821,42,0.51 [0.23-1.15],0.1039318408358974
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20880,101,1.13 [0.83-1.53],0.436928680246491
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20830,51,1.17 [0.78-1.76],0.446241154035135
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20833,54,1.11 [0.73-1.69],0.6300872112024896
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20820,41,0.98 [0.56-1.71],0.9460265488111496
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20963,184,1.21 [0.99-1.49],0.0676491647304455
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20824,45,1.47 [1.08-2.02],0.0158144447303696
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20822,43,1.32 [0.90-1.93],0.1591736014775804
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20872,93,1.11 [0.80-1.53],0.5417392158429388
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20845,66,1.02 [0.67-1.56],0.9137292726370856
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21157,378,1.19 [1.03-1.38],0.0220507861678508
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20910,131,0.82 [0.57-1.17],0.2767783245386918
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20979,200,1.31 [1.10-1.57],0.0028366155427732
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22622,89,1.40 [1.10-1.79],0.0068227432356314
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22825,292,1.04 [0.85-1.26],0.7293484336914043
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22580,47,0.76 [0.41-1.43],0.3985494568620348
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22590,57,0.81 [0.47-1.38],0.4404355663205369
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22634,101,0.88 [0.60-1.29],0.5033839916101124
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20192,3735,1.01 [0.95-1.08],0.7196975026192434
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9660,342,0.95 [0.77-1.17],0.6296149126408332
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22557,157,0.69 [0.48-1.00],0.0476633170446915
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22443,43,0.58 [0.27-1.24],0.1610976453841121
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Acute renal failure,22703,33,0.58 [0.24-1.40],0.2271274305933721
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22699,29,1.05 [0.56-1.95],0.8874949770672103
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22707,37,0.90 [0.48-1.67],0.7326580715555422
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Urolithiasis,23514,197,0.91 [0.70-1.19],0.4954671705476734
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23587,47,0.45 [0.20-1.01],0.051852334134902
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23453,136,0.94 [0.69-1.28],0.6917550767686217
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23400,83,0.68 [0.41-1.13],0.1374168785535373
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22527,754,0.98 [0.86-1.12],0.7916903300931184
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Cystitis,21841,68,1.01 [0.67-1.53],0.9514894197191894
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21829,56,0.92 [0.57-1.51],0.7498057345877551
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21927,154,1.02 [0.78-1.34],0.8865910651196566
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Urethral stricture,21854,81,0.90 [0.59-1.36],0.6167513768920931
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22304,531,1.01 [0.87-1.17],0.8763911990397308
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9379,61,0.98 [0.62-1.57],0.948190958350203
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9349,31,0.93 [0.47-1.83],0.8302426826742468
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Hydrocele,9351,33,0.88 [0.44-1.78],0.7304379212504605
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9390,72,0.90 [0.56-1.44],0.6643453087178354
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9375,57,1.05 [0.68-1.63],0.8342594853351113
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9398,80,0.90 [0.58-1.40],0.6443866270291954
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Disorders of breast,13035,218,1.15 [0.95-1.39],0.1614744507693138
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12883,66,1.12 [0.79-1.60],0.5257645519546089
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,12889,72,1.07 [0.75-1.53],0.7004568996608214
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12865,48,1.21 [0.83-1.77],0.3246354170489657
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12997,332,1.04 [0.88-1.24],0.6439570671857247
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,12736,71,1.02 [0.70-1.49],0.8981505641674269
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12830,165,0.97 [0.75-1.25],0.8061767600285249
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11994,2346,1.02 [0.95-1.10],0.5936939743082972
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Endometriosis,9897,249,0.96 [0.77-1.20],0.7088584419058932
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,9728,80,0.75 [0.47-1.21],0.2395694857280084
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9744,96,1.11 [0.82-1.50],0.5006426931347175
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9913,265,1.04 [0.85-1.27],0.6984673844309774
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9907,259,1.02 [0.83-1.25],0.8429309138971958
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10050,402,0.95 [0.79-1.13],0.546860134856002
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Uterine polyps,9790,142,0.95 [0.71-1.28],0.7476859025098805
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9832,184,0.90 [0.69-1.18],0.4614156398906985
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9715,67,1.11 [0.78-1.59],0.5495459607934918
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9774,126,1.02 [0.76-1.36],0.9097293204653376
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",13161,176,1.11 [0.90-1.38],0.3282379627988241
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,13168,169,1.13 [0.91-1.41],0.2661508627188693
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,13184,95,1.31 [1.03-1.66],0.0267305883702293
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",13178,103,1.27 [1.00-1.61],0.0491689629142197
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9706,58,1.17 [0.82-1.69],0.3903331479145937
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9700,52,1.39 [1.03-1.87],0.0319221499284993
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9708,60,0.98 [0.63-1.52],0.9234181057355186
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Irregular menses,13097,315,0.88 [0.71-1.08],0.2255272455545997
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10613,965,1.05 [0.95-1.17],0.3408422032287674
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Menorrhagia,10309,661,1.10 [0.98-1.24],0.1064720365654878
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",13169,137,0.87 [0.63-1.19],0.3797548622948997
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9945,297,1.06 [0.88-1.27],0.5376784575133549
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9868,220,1.04 [0.84-1.28],0.7407241653080574
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9871,223,1.09 [0.88-1.35],0.4337771033208059
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Female infertility,9732,84,1.07 [0.77-1.50],0.6746498557423033
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",9725,77,1.16 [0.84-1.59],0.3661102143113951
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,13178,719,0.87 [0.75-1.01],0.0647649206251423
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,13186,990,0.90 [0.79-1.02],0.0912722689841617
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,13179,374,0.76 [0.61-0.95],0.0145881719389689
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,12910,105,0.84 [0.58-1.22],0.3615939303548068
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,12956,151,0.72 [0.51-1.02],0.0622256364592031
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,12938,133,0.79 [0.55-1.13],0.1913258652230344
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",13194,138,1.11 [0.87-1.42],0.3936523740416419
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,13196,136,1.11 [0.87-1.42],0.4099495631109835
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,13192,351,1.15 [0.98-1.35],0.079875598273443
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,12942,101,1.03 [0.74-1.44],0.8433219762015174
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,13040,199,1.22 [1.00-1.47],0.0449611658986154
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,12583,124,0.94 [0.69-1.27],0.6693669676034244
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,12622,163,0.90 [0.68-1.20],0.4815220596140594
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,12659,200,1.03 [0.83-1.28],0.7659381639794642
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,12580,121,0.99 [0.74-1.32],0.9187019574702572
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",False labour,12572,113,0.69 [0.45-1.04],0.0734908397283354
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,12582,123,1.01 [0.76-1.34],0.9526306500201984
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Long labour,12387,191,0.93 [0.72-1.20],0.5556834154968424
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],12564,368,0.93 [0.78-1.12],0.4742098270085292
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,12747,551,0.94 [0.80-1.10],0.4200050307265606
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",13199,145,0.88 [0.65-1.20],0.4197932938923827
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,11999,110,0.92 [0.66-1.30],0.6554384026795879
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",12281,85,1.12 [0.83-1.50],0.4607434925506806
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Delivery,13203,280,1.02 [0.84-1.24],0.8120373290589925
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,13142,219,1.09 [0.89-1.33],0.4069936000223458
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",13192,203,1.04 [0.83-1.30],0.7238225148383359
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",13183,194,1.07 [0.86-1.33],0.562436320444849
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23620,32,0.90 [0.46-1.76],0.7543160120146075
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Falls/tendency to fall,22420,442,1.02 [0.87-1.20],0.7667922167201761
